Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.
Clouds background image

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page

  1. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-28T08:30:47.000Z thumbnail image
  2. Check
    73 days ago
    Change Detected
    Summary
    The page has been updated to include new information about metastatic non-small cell lung cancer and a new version revision, while significant details about a Phase 3 study and its criteria have been removed.
    Difference
    3%
    Check dated 2025-04-21T02:20:53.000Z thumbnail image
  3. Check
    89 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 22, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-05T13:12:57.000Z thumbnail image
  4. Check
    96 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new revision version (v2.14.3) and a new date for the results first posted, changing from January 22, 2025, to March 25, 2025.
    Difference
    0.2%
    Check dated 2025-03-28T23:17:59.000Z thumbnail image
  5. Check
    161 days ago
    Change Detected
    Summary
    The study has expanded to include 343 locations across various states and countries, with new results expected to be posted on January 22, 2025, while previous results and locations have been removed.
    Difference
    99%
    Check dated 2025-01-22T22:08:49.000Z thumbnail image
  6. Check
    168 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-15T18:24:49.000Z thumbnail image

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.